EAN News

Prof. David B. Vodušek (DBV): Kindly illustrate the history, vision and mission of the EANM – European Association of  Nuclear Medicine to the readers of the EAN Pages. Prof. K. Muylle (KM): The European Association of Nuclear Medicine (EANM) is a professional non-profit medical association, incorporated in Vienna/Austria. The EANM’s vision is to optimise and advance science and education in nuclear medicine for the benefit of public health and humanity within the concept of personalised healthcare. The EANM acts as umbrella organisation for individuals as well as national societies.

Despite its large use, recommendations for the use of brain F-18 FDG-PET in clinical practice were still lacking. The European Academy of Neurology (EAN) and the European Association of Nuclear Medicine (EANM) promoted a concerted action with 7 specialists from the two Societies and a group of facilitators in order to make the point on this issue. Extensive literature review and analysis of available data led, together with expert opinion (Delphi consensus), to deliver these recommendations that cover practically all the main brain neurodegenerative conditions causing cognitive impairment.

The Guideline will address important areas of dementia management where the medical doctor plays a pivotal role, which includes treatment of epilepsy in dementia, pain in dementia, treatment with antipsychotics in dementia, vascular risk factors in dementia and systematic medical follow-up in dementia.

Prof. Elena Moro (EM): Dear Prof. Hallett, it is a great honor for me, as movement disorders specialist, to ask you few questions on behalf of the EAN members and for all EAN pages readers. In light of your Honorary Membership to the EAN, can you tell us what did make you choose “neurology” as the specialty to pursue? Prof. Mark Hallett (MH): I have been interested in the brain since I took a psychology course in high school.  I pursued neuroscience studies in college, but only decided to go into medicine about half way through college. 

Dear EAN Members, dear Colleagues, The 4th annual Congress of the European Academy of Neurology just held in Lisbon on June 16th - 19th was a spectacular event. More than 6,700 participants from 104 countries attended the meeting which covered the whole range of neurologic disorders in various formats, and offered altogether 42 scientific and 48 educational sessions. Besides several teaching courses and educational activities, the congress also comprised of 20 case-based workshops and interactive sessions, 7 hands-on courses, and 3 career development sessions.

For July 2018, we have selected: Thomalla G, Simonsen CZ, Boutitie G, et al., for the WAKE-UP Investigators. MRI-guided thrombolysis for stroke with unknown time of onset. NEJM May 16, 2018. doi:10.1056/NEJMoa1804355. Thrombolysis is currently performed in patients with acute ischemic stroke within a window of 4.5 hours since the symptoms’ onset. In about one third of the patients, the exact time of stroke onset is unknown, like in patients who wake up from sleeping.

oland is located in Central Europe between the Baltic Sea in the north, and the Sudetes and the Carpathian Mountains in the south, the majority of the area laying in the basin of the Vistula and Oder rivers. The country is inhabited by about 38 million people, and in terms of the area, which exceeds 300,000. km2, Poland is classified as 63rd on Earth. Its neighbours are: Germany, the Czech Republic, Slovakia, Ukraine, Belarus, Lithuania and Russia.

Highlights and late breaking news session 19.06.2018 by Tim von Oertzen This session was chaired by the outgoing EAN president Prof Gunther Deuschl, the chair of the Programme Committee, Prof Paul Boon, the incoming EAN president Franz Fazekas and the… Continue Reading

Meet and greet – 18 June 2018
By Martin Rakusa After the long day at the congress, more than 200 neurologists gathered at the traditional “Meet and greet” event. Among others, the past and the new EAN presidents, the members… Continue Reading

Symposium 7: A new look at the neuropathogenesis of multiple sclerosis   June 19, 2018   By Tom Jenkins   The field of multiple sclerosis (MS) has been revolutionized over the last 20 years by exponential growth in therapeutic options, driven by… Continue Reading

Lisbon 2018: Report on Symposium 6:   Coma: neuromodulation, imaging and neurobiology June 18th, 2018 by Antonella Macerollo This symposium was chaired by Prof Laureys, Belgium, and Dr Diserens, Switzerland. Dr Kondziella from Denmark gave the first presentation titled: Mechanisms of… Continue Reading

Symposium 5: Spectrum of dementias  18 June 2018  By Martin Rakusa  The symposium was chaired by Prof. Jonathan M. Schott from London, United Kingdom, and Prof. Evelien Lemstra from Amsterdam, The Netherlands. Aim of the symposium was to cover four… Continue Reading

The newly elected delegates representing the full members and delegates appointed newly by their national societies met for the first time in Lisbon during the annual meeting of the EAN. This assembly has been elected (or appointed) for the next 4 years, and will meet again in Oslo (2019), Paris (2010) and Vienna (2021).

Sofia Duque (EuGMS – European Geriatric Medicine Societies), Paul Boon and David B. Vodusek (EAN) met during the EAN congress to intensify the between the two organisations. The goal is to improve the care and research of elderly neurological patients… Continue Reading